Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation
de Gast, G.C.; Beatty, P.G.; Amos, D.; Sullivan, K.; Anderson, J.E.; Thomas, E.D.; Hansen, J.A.
Transplantation Proceedings 19(1 Pt 3): 2700
1987
ISSN/ISBN: 0041-1345 PMID: 3274581 Document Number: 299287
Document emailed within 1 workday
Related Documents
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758Smyth, L.A.; Witt, C.S.; Christiansen, F.T.; Herrmann, R.P.; Hollingsworth, P.N.; Townend, D.C.; Edward, E.; Dawkins, R.L. 1993: The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation Bone Marrow Transplantation 12(4): 351-355
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Lachance, S.; Le Gouvello, S.; Roudot, F.; Kuentz, M.; Bernaudin, F.; Beaujean, F.; Bierling, P.; Cordonnier, C.; Farcet, J.P.; Vernant, J.P. 1997: Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies Transplantation 64(8): 1147-1152
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Apperley, J.F.; Jones, L.; Hale, G.; Waldmann, H.; Hows, J.; Rombos, Y.; Tsatalas, C.; Marcus, R.E.; Goolden, A.W.; Gordon-Smith, E.C. 1986: Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse Bone Marrow Transplantation 1(1): 53-66
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Nevo, S.; Enger, C.; Swan, V.; Wojno, K.J.; Fuller, A.K.; Altomonte, V.; Braine, H.G.; Noga, S.J.; Vogelsang, G.B. 1999: Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival Transplantation 67(5): 681-689
Bär, B.M.; Schattenberg, A.; De Man, A.J.; Hoogenhout, M.J.; Boezeman, J.; de Witte, T. 1992: Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow Bone Marrow Transplantation 10(1): 45-52
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Huang, X.; Guo, N.; Ren, H.; Zhang, Y.; Gao, Z.; Lu, D. 2003: An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation Chinese Medical Journal 116(5): 736-741
de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Izzi, T.; Lucarelli, G. 1983: Bone marrow transplantation in humans. IV. the graft versus host disease Recenti Progressi in Medicina 74(6): 720-732
Tratkiewicz, J.A.; Szer, J. 1987: Prediction of leukemic relapse soon after bone marrow transplantation Transplantation Proceedings 19(1 Part 3): 2648-2650
Hovdenes, J.; Solheim, B.G. 1995: Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(12): 1499-1501
Cooper, M.H.; Hartman, G.G.; Starzl, T.E.; Fung, J.J. 1991: The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506 Transplantation Proceedings 23(6): 3234-3235
Devergie, A.; Esperou, H.; Traineau, R.; Varrin, F.; Lehn, P.; Gluckman, E. 1989: Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation Nouvelle Revue Francaise d'Hematologie 31(2): 73-75
Slavin, S.; Or, R.; Cividalli, G.; Brautbar, C.; Hale, G.; Waldmann, H.; Rachmilewitz, E. 1988: Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease Birth Defects Original Article Series 23(5b): 313-316